Blog Archives

PRESS RELEASE: $1.5M NIH Funding To Expand Parkinson’s Telemedicine To Mobile Apps

VIEW PRESS RELEASE 15 APR 2014: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they will be using a $1.5M award from NIH to expand their Parkinson’s monitoring technology to mobile applications. Repositioning GLNT’s Kinesia™ product line with mobile apps strategically aligns with growing trends in domestic and

Read more ›


PRESS RELEASE: Great Lakes NeuroTechnologies Launches Study to Automatically Classify Abnormal Muscle Tone in Movement Disorders

VIEW PRESS RELEASE [PDF] 15 JAN 2014: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that it is launching a study to determine the feasibility of a clinician-worn glove to objectively evaluate abnormal muscle tone, such as stiff joints or muscle tightness, due to neurological disorders.


PRESS RELEASE: GLNT Awarded Patent For Sensor Based Continuous Parkinson’s Assessment During Daily Activities

VIEW PRESS RELEASE [PDF] 03 DEC 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received allowance of claims from the U.S. Patent Office for an application covering their system and method of continuous monitoring of motor symptoms associated with movement disorders such as Parkinson’s disease. The

Read more ›


PRESS RELEASE: Great Lakes NeuroTechnologies Secures $1.7 Million to Develop Continuous Dyskinesia Monitoring Technology for Parkinson’s Disease

VIEW PRESS RELEASE [PDF]  05 Mar 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that they are launching commercialization and clinical studies to validate a system for objective, continuous monitoring of dyskinesias associated with Parkinson’s disease. The study is being funded by a $1,743,051 Phase II Small

Read more ›


PRESS RELEASE: Great Lakes NeuroTechnologies Launches Study to Develop Intelligent Algorithms for Programming Deep Brain Stimulation in Parkinson’s

VIEW PRESS RELEASE [PDF] 22 JAN 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that they are launching a study to determine the feasibility of using intelligent algorithms to assist with programming deep brain stimulation settings for Parkinson’s disease.   The study is being funded by a $283,828

Read more ›


PRESS RELEASE: GLNT Secures Over $4.5 Million in Funding to Fuel New Product Development for Parkinson’s Disease and Neuroscience Education

VIEW PRESS RELEASE [PDF] April 24, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today they have secured over $4.5 million is funding for new product development. The funding includes three new projects sponsored by the National Institutes of Health’s SBIR program. Each project is focused on developing and

Read more ›


PRESS RELEASE: GLNT Tackles Continuous Monitoring of Essential Tremor with Launch of Multi-Site Clinical Study

VIEW PRESS RELEASE [PDF] April 5, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today they have launched a multi-site clinical study to assess continuous monitoring of essential tremor (ET) using their Kinesia technology platform. A preliminary study published in 2011 in the journal Parkinsonism and Related Disorders demonstrated

Read more ›


PRESS RELEASE: GLNT Begins Clinical Study to Demonstrate High Sensitivity Motor Symptom Detection in Parkinson’s Disease

VIEW PRESS RELEASE [PDF] March 23, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they have begun a clinical study to assess the sensitivity of their Kinesia system to detect subtle motor function changes in patients with Parkinson’s disease (PD). The study, funded by the National Institutes

Read more ›


PRESS RELEASE: Great Lakes NeuroTechnologies Receives Nearly $2 Million In New Funding To Expand Home-Based Technologies For Monitoring Movement Disorders

VIEW PRESS RELEASE [PDF] 01 SEPT 2011: Cleveland OH – Great Lakes NeuroTechnologies was recently awarded two NIH SBIR grants: $1.7 million in Phase II funding from the National Institute on Aging to develop ETSense ™, an adaptive, portable essential tremor (ET) monitor and $256,000 in Phase I funding from

Read more ›


PRESS RELEASE: Great Lakes NeuroTech’s BioRadio and Vivonoetic Inc.’s VivoSense Used in Prematurity and Respiratory Outcomes Program Multicenter Study

VIEW PRESS RELEASE [PDF] Cleveland, OH – August 1, 2011 – Great Lakes NeuroTech’s BioRadio and Vivonoetics Inc.’s VivoSense software are being used for the Prematurity and Respiratory Outcomes Program  (PROP, http://www.urmc.rochester.edu/pediatrics/pedsnews/july-10/prop.cfm) multicenter clinical study to examine the respiratory outcome of premature babies over the next three years. PROP is

Read more ›